Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Insmed Inc (INSM)

Insmed Inc (INSM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Insmed: Q4 Earnings Snapshot

Insmed: Q4 Earnings Snapshot

INSM : 24.32 (-1.94%)
Insmed: Q3 Earnings Snapshot

Insmed: Q3 Earnings Snapshot

INSM : 24.32 (-1.94%)
Insmed to Host Third-Quarter 2023 Financial Results Conference Call on Thursday, October 26, 2023

/PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...

INSM : 24.32 (-1.94%)
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

/PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...

INSM : 24.32 (-1.94%)
Why Shares of Insmed Are Soaring This Week

The biotech company announced positive top-line trial results and received upgrades from analysts.

BAC : 36.97 (+3.35%)
INSM : 24.32 (-1.94%)
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

/PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...

INSM : 24.32 (-1.94%)
Why Insmed Stock Is Soaring Today

Investors applauded the company's latest clinical results.

INSM : 24.32 (-1.94%)
The Five Biotech Stocks Every Investor Should Know About

Avalon GloboCare Corp., (NASDAQ: ALBT) a developer of innovative precision diagnostics and provider of clinical laboratory services just announced that the United States Patent and Trademark Office (USPTO)...

ALBT : 0.3055 (-2.02%)
INSM : 24.32 (-1.94%)
VIR : 7.95 (-0.13%)
CODX : 1.1500 (-0.86%)
ANTX : 2.47 (+3.78%)
A Potentially Revolutionary Tuberculosis Test Can Produce Results in 24 Hours

With a rising prevalence of chronic diseases, we’re starting to see higher demand for clinical lab services. That being said, it’s no surprise that, according to Market.Us, the global market for clinical...

INSM : 24.32 (-1.94%)
VIR : 7.95 (-0.13%)
CODX : 1.1500 (-0.86%)
ANTX : 2.47 (+3.78%)
ALBT : 0.3055 (-2.02%)
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

/PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...

INSM : 24.32 (-1.94%)

Barchart Exclusives

Dividend Newcomers: Discover 3 Companies Starting To Share the Wealth
Discover the potential of newly initiated dividends—start building your wealth with tomorrow's top dividend payers today! Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar